Receive our newsletter – data, insights and analysis delivered to you
In association with GlobalData
  1. Research Reports
November 18, 2019

More and more people take seasonal influenza vaccinations, says GlobalData

By Imogen Clegg

The coming of ‘flu season’ every year causes patients of all backgrounds to visit their GP for vaccination. Seasonal influenza is a highly contagious respiratory virus, of which there are four types: A, B, C and D. These affect humans in different ways; however, only types A and B cause human disease of public health concern (WHO, 2014).

The disease can be transmitted in a number of ways: the main transmission methods include coughing, sneezing and speech, all of which can disseminate droplets that come into contact with the nose and mouth, and are inhaled. Once in the lungs, the virus starts to spread and cause infection.

An increasing number of patients will receive the seasonal influenza vaccination up to 2028

GlobalData’s research describes the epidemiology of seasonal influenza cases over the period 2018–2028. In 2018, the eight major markets (8MM) had 4,406,548 diagnosed incident cases, and this is expected to decrease to 4,285,297 by 2028 at an annual growth rate of -0.28%.

An increasing number of people will receive the seasonal influenza vaccination, rising from 380,179,080 to 409,507,606 in 2028. Expert epidemiologists used age- and sex-specific diagnosed prevalent rates to forecast diagnosed cases.

Key highlights of this report include:

  • In-depth and high-quality reporting, providing key analysis of disease trends
  • 10-year epidemiological forecast for laboratory-confirmed seasonal influenza, laboratory-confirmed seasonal influenza mortality, and vaccination rates
  • Interactive dashboards with transport and consistent methodologies
  • An overview of the biggest trends and risk factors associated with seasonal influenza

 

The report ‘Seasonal Influenza: Epidemiology Forecast to 2028’ will allow you to gain key insights into seasonal influenza epidemiology and plan business strategies accordingly. Quantify patient populations in the global seasonal influenza market improve decision-making. This report can allow you to gain a competitive edge and utilise key historical and forecast data to maximise business opportunities.

Content from our partners
How Hengst helped to keep Germany’s charity “star singers” shining
Why this global life sciences COO believes relocation to Charleston, SC, was key to achieving next-level success
Patient-centric pharma logistics: How CRYOPDP delivers hope worldwide

 

To find out more about this and other reports, visit the GlobalData Report Store

 

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU